As advised via PHARMAC tender of 30 April 2018 there is to be a change in the listing and future sole supply.

New listing from 1 October 2018

Siterone Tab 50 mg 50                                                     Pharmacode 2220482    Schedule price $13.17

Siterone Tab 100 mg 50                                                   Pharmacode 2235862    Schedule price $26.75

Incumbent brand

Procur Tab 50 mg  50                                                       Pharmacode  478865 Schedule price $15.87

Procur Tab 100 mg  50                                                     Pharmacode  2212811 Schedule price $30.40

Reference pricing will apply to the incumbent from 1 December 2018 and delisting 1 March 2019.

As of the date of this notification ProPharma / PWR cannot accept Procur Tabs for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

Benefit of staying with incumbent – With a variable or reducing margin every cent counts.

50 mg:- $15.87 x 3% = $0.4761 plus $0.238 per pack fee = $0.7141 compared to $13.17 x 3% = $0.3951 plus $0.238 per pack fee = $0.6631

100 mg:- $30.40 x 3% = $0.9120 plus $0.238 per pack fee = $1.1500 compared to $26.75  x 3% = $0.8025 plus $0.238 per pack fee = $1.0405

You MUST manage your stock so that you have ZERO stock at time of reference pricing being 1 December 2018 or have been advised of supplier price change/support earlier. No matter what you must manage your stock accordingly.

Once again we need your support to ensure stock in the supply chain moves through to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author

Close